Xynos Konstantinos — SEC Form 4 filings
SEC reporting owner CIK 1956241. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-04-03 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 70,164 shares, $588,168 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 11,447 shares @ $12.97 ($148,468) in Replimune Group, Inc., filed 2026-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Replimune Group, Inc. (REPL) | Chief Medical Officer | 11 | — | 7 legs · 70,164 sh · $588,168 | 7 |
Form 4 filings — Xynos Konstantinos
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 11,447 @ $12.97 | EDGAR |
| 2026-05-20 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 14,023 @ $5.08 | EDGAR |
| 2026-04-07 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 60,000 @ $0 | EDGAR |
| 2025-11-19 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 7,248 @ $9.10 | EDGAR |
| 2025-05-22 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 7,952 @ $8.06 | EDGAR |
| 2025-04-03 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 45,000 @ $0 · Grant/award (A): 67,500 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 7,246 @ $10.78 | EDGAR |
| 2024-06-10 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 15,881 @ $7.50 | EDGAR |
| 2024-05-20 | 4 | Replimune Group, Inc. (REPL) | Sale (S): 6,367 @ $6.47 | EDGAR |
| 2024-04-03 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 26,665 @ $0 · Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1956241 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →